13,385 total adverse events, including 801 rated as serious and 14 reported deaths among 12- to 17-year-olds. Two of the nine deaths were suicides.
The most recent reported death includes a 13-year-old boy (VAERS I.D. 1431289) with a previous history of COVID who suffered cardiac arrest and died 17 days after vaccination with Pfizer.Other reports include a 13-year-old boy (VAERS I.D. 1406840) who died two days after receiving a Pfizer vaccine, three 15-year-olds (VAERS I.D. 1187918, 1382906 and 1242573), four 16-year-olds (VAERS I.D. 1420630, 1426828, 1225942 and 1386841) and three 17-year-olds (VAERS I.D. 1199455, 1388042 and 1420762).
1,934 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases
attributed to Pfizer’s vaccine, 1.1% to Moderna and 0.2% (or four cases) to J&J.
347 reports of myocarditis and pericarditis (heart inflammation) with 343 attributed to Pfizer’s vaccine.
57 reports of blood clotting disorders, 56 attributed to Pfizer and 1 attributed to Moderna.
This week’s total VAERS data, from Dec. 14, 2020 to July 2, 2021, for all age groups show:
22% of deaths were related to cardiac disorders.
50% of those who died were male, 45% were female and the remaining death reports did not include gender of the deceased.
The average age of death was 74.7.
As of July 2, 2,678 pregnant women reported adverse events related to COVID vaccines, including 994 reports of miscarriage or premature birth.
Of the 4,456 cases of Bell’s Palsy reported, 59% were attributed to Pfizer vaccinations, 39% to Moderna vaccine and 7% to J&J.
398 reports of Guillain-Barré Syndrome, with 47% of cases attributed to Pfizer, 40% to Moderna and 19% to J&J.
121,092 reports of anaphylaxis with 46% of cases attributed to Pfizer’s vaccine, 46% to Moderna and 7% to J&J.
8,256 reports of blood clotting disorders. Of those, 3,959 reports were attributed to Pfizer, 2,699 reports to Moderna and 1,552 reports to J&J.
1,796 cases of myocarditis and pericarditis with 1,177 cases attributed to Pfizer, 563 cases to Moderna and 52 cases to J&J’s COVID vaccine.
Pfizer says boosters needed, U.S. federal health agencies, scientists disagree
As The Defender reported today, U.S. federal health agencies and the maker of one of the most popular COVID vaccines are publicly at odds over if or when fully vaccinated people will need a third “booster” dose.
Pfizer announced Thursday it will seek Emergency Use Authorization from the FDA in August for a third dose of its COVID vaccine. The drugmaker predicted those who have been fully vaccinated will need a booster shot within six to 12 months of receiving their second dose of the Pfizer vaccine.
But the U.S.Department of Health and Human Services (HHS) hours later issued a joint statement by the FDA and Centers for Disease and Control and Prevention (CDC) saying, “Americans who have been fully vaccinated do not need a booster shot at this time.”
Tell Schools/Universities No Vaccine Mandates for Children/Young Adults!
Hundreds injured by COVID vaccines turn to GoFundMe for help
vollständig: